Did you mean 5108 205 6?
Displaying drugs 4101 - 4125 of 5652 in total
COTI-2
Investigational
Cpad
Experimental
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[(2R,3S,4R,5S)-5-(6-carbamoylpyridin …
Deamido-Nad+
Experimental
Matched Iupac: … 1-[(2R,3R,4S,5R)-5-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy …
2,6-dibromo-4-[(E)-2-phenylethenyl]phenol
Experimental
4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL
Experimental
S-(2-oxo)pentadecylcoa
Experimental
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3S)-3-hydroxy-2,2-dimethyl …
Nicotinamide adenine dinucleotide cyclohexanone
Experimental
Matched Iupac: … 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy …
2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol
Experimental
AT-7519
AT7519 is a selective inhibitor of certain Cyclin Dependent Kinases (CDKs) leading to tumour regression. It is developed by Astex for the treatment of solid tumours and haematological malignancies.
Investigational
Phytic acid
Phytic acid is under investigation in clinical trial NCT01000233 (Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications).
Investigational
Inavolisib
Inavolisib (GDC-0077) is under investigation in clinical trial NCT03006172 (To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer).
Investigational
Polyhexamethyleneguanidine
Investigational
Deudomperidone
Deudomperidone is under investigation in clinical trial NCT05832151 (A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis).
Investigational
Dipropylene glycol
Experimental
HG004
Investigational
S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE
Experimental
PCLX-001
PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by Pacylex Pharmaceuticals (https://pacylex.com). Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high activity and positive results in breast, lung, bladder and pancreas cancers.
Investigational
Dihydrouridine
Investigational
Indralin
Investigational
Recombinant neuroglobin
Investigational
5-hydroxymethyl-5,6-dihydrofolic acid
Experimental
Matched Iupac: … (2S)-2-{[4-({[(6S)-2-amino-5-(hydroxymethyl)-4-oxo-3,4,5,6-tetrahydropteridin-6-yl]methyl}amino)phenyl …
4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL
Experimental
Displaying drugs 4101 - 4125 of 5652 in total